Artrya Limited (AYA.AX)
- Previous Close
0.3100 - Open
0.3100 - Bid 0.3100 x --
- Ask 0.3700 x --
- Day's Range
0.3100 - 0.3100 - 52 Week Range
0.1600 - 0.4200 - Volume
5,148 - Avg. Volume
49,988 - Market Cap (intraday)
24.398M - Beta (5Y Monthly) 0.69
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date Feb 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.
www.artrya.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: AYA.AX
Performance Overview: AYA.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AYA.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AYA.AX
Valuation Measures
Market Cap
24.40M
Enterprise Value
10.05M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.03
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-0.87
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-23.41%
Return on Equity (ttm)
-39.26%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-11.56M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
15.43M
Total Debt/Equity (mrq)
4.54%
Levered Free Cash Flow (ttm)
-8.6M
Company Insights: AYA.AX
AYA.AX does not have Company Insights